The field of medicinal chemistry relies heavily on precise chemical structures to develop effective treatments. (3S,4S)-3-Hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone, identified by its CAS number 68711-40-0, stands out as a significant compound within this domain. Its primary significance lies in its role as an essential pharmaceutical building block, particularly for the synthesis of Orlistat, a well-known anti-obesity drug.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing researchers and manufacturers with high-quality chemical compounds like this oxetanone derivative. The compound's specific stereochemistry and purity are critical for its application as an Orlistat impurity standard, vital for rigorous quality control in pharmaceutical production. Ensuring the accurate identification and quantification of impurities is a non-negotiable aspect of drug safety and efficacy.

The detailed chemical synthesis of (3S,4S)-3-Hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone involves intricate steps to achieve the desired chiral configuration. This process is a testament to the advanced capabilities required in modern chemical manufacturing. As an analog of Tetrahydrolipstatin, it also opens avenues for research into novel therapeutic agents targeting similar biological pathways.

For professionals in drug discovery and development, understanding the nuances of compounds like CAS 68711-40-0 is paramount. Its consistent availability and quality, as provided by NINGBO INNO PHARMCHEM CO.,LTD., support the ongoing efforts to refine existing drugs and discover new ones. The chemical formula C22H42O3 hints at its lipophilic nature, influencing its solubility and handling characteristics in various laboratory settings.

The strategic sourcing of such advanced intermediates is a key differentiator for pharmaceutical companies. NINGBO INNO PHARMCHEM CO.,LTD. aims to be a trusted partner, supplying the necessary pharmaceutical intermediates that underpin critical drug manufacturing processes, thereby contributing to improved health outcomes globally.